Summary
In Episode 4 of the Leap Together podcast, we sit down with Dr. Raymond Douglas, world-renowned oculoplastic surgeon, Chief Scientific Officer at Sling Therapeutics, and lead scientific contributor behind Tepezza, the first FDA-approved treatment for Thyroid Eye Disease (TED).
Dr. Douglas shares his career journey from oncology and immunology research to becoming a pioneer in ophthalmology and thyroid eye disease treatment. He discusses how personal patient experiences inspired his work in surgical innovation and medical therapies, and why addressing access to clinical trials is critical to delivering better outcomes for underserved patient populations.
Key Topic Include:
- The development of Tepezza and its impact on TED patients
- The promise of personalized medicine through biologic registries and predictive diagnostics
- Barriers in clinical trial access—especially for global and underrepresented communities
- How AI and collaboration can break silos in clinical research
- The evolving role of academic institutions vs. private practice in delivering care
- Future innovations in ophthalmology, including treatments for presbyopia and retinal disease
This episode is a must-listen for anyone interested in clinical research, translational medicine, patient advocacy, and healthcare innovation. Dr. Douglas offers deep insights into how science and empathy can come together to change lives.
Listen now above or at: https://lpcur.com/LeapTogetherEp4
Leave a Reply